RECODE THERAPEUTICS, INC. — Form D

RECODE THERAPEUTICS, INC. of Menlo Park, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-20. The offering totals $80.0M, of which $27.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (30)

Showing 25 of 30 people.

NameRoleLocation
Edward J HurwitzDirectorMenlo Park, CA
Helen J KimDirectorMenlo Park, CA
David J LockhartDirectorMenlo Park, CA
RA J Session IIDirectorMenlo Park, CA
Peter J ThompsonDirectorMenlo Park, CA
Michael J TorresDirectorMenlo Park, CA
David J LockhartExecutive OfficerMenlo Park, CA
Peter A ThompsonDirectorNew York, NY
Rana S Al-HallaqDirectorMenlo Park, CA
Patricia S MillicanDirectorMenlo Park, CA
Shehnaaz SulimanDirectorMenlo Park, CA
Shehnaaz SulimanExecutive OfficerMenlo Park, CA
Shehnaaz SulimanPromoterMenlo Park, CA
Edward S HurwitzDirectorMenlo Park, CA
Alan S ColowickDirectorMenlo Park, CA
David S LockhartExecutive OfficerMenlo Park, CA
Dean S MitchellDirectorMenlo Park, CA
Basheer S ZadaDirectorMenlo Park, CA
Inai S ParkDirectorMenlo Park, CA
Helen S KimDirectorMenlo Park, CA
Rakhshita S DharDirectorMenlo Park, CA
Oleg S NodelmanDirectorMenlo Park, CA
Kouki S HarasakiDirectorMenlo Park, CA
Trisha S MillicanDirectorMenlo Park, CA
Shehnaaz S SulimanDirectorMenlo Park, CA

Other filings by this issuer (8)

FiledFormOfferingSold
2025-10-23D$29.4M$29.4M
2023-09-28D/A$290.0M$259.8M
2023-01-27D/A$220.8M$210.0M
2022-07-06D/A$200.0M$160.0M
2021-10-25D$80.0M$40.0M
2019-02-08D/A$3.0M$2.0M
2017-03-02D/A$3.0M$1.0M
2017-01-05D$3.0M$500K

More